Dimed S.A. Distribuidora de Medicamentos (BVMF:PNVL3)

BVMF:PNVL3 Revenue

Dimed S.A. Distribuidora de Medicamentos had revenue of 1.45B BRL in the quarter ending March 31, 2026, with 15.17% growth. This brings the company's revenue in the last twelve months to 5.70B, up 14.63% year-over-year. In the year 2025, Dimed S.A. Distribuidora de Medicamentos had annual revenue of 5.51B with 11.53% growth.

• Revenue (ttm): 5.70B
• Revenue Growth: +14.63%
• P/S Ratio: 0.34
• Revenue / Employee: 505.50K
• Employees: 11,282
• Market Cap: 1.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.51B	569.66M	11.53%
Dec 31, 2024	4.94B	481.45M	10.79%
Dec 31, 2023	4.46B	470.54M	11.79%
Dec 31, 2022	3.99B	765.07M	23.72%
Dec 31, 2021	3.23B	406.30M	14.41%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error